Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study
Condition:   Opioid-use Disorder Intervention:   Behavioral: Reminders messages to improve adherence. Sponsors:   Washington State University;   National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2020 Category: Research Source Type: clinical trials

Providing Suboxone and PrEP Using Telemedicine
Conditions:   Opioid Use;   Opioid-use Disorder;   Risk Reduction;   Hiv Interventions:   Drug: Suboxone;   Drug: PrEP Sponsor:   Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2020 Category: Research Source Type: clinical trials